Associated Papers
A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation.
Salgado J et al.
Oncology Letters, 2011
Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.
Miramar MD et al.
Breast Cancer Research and Treatment, 2008
Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.
Judkins T et al.
Cancer Research, 2005
Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
Baeyens A et al.
International Journal of Radiation Biology, 2004
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.
Papelard H et al.
British Journal of Cancer, 2000
Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
Claes K et al.
Disease Markers, 1999
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
Claes K et al.
Human Mutation, 1999
Select a paper to view details